PATRICK J. SCANNON, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

XOMA Royalty Corp

Filing Date Source Excerpt
2010-06-09 Patrick J. Scannon, M.D., Ph.D. Executive Vice President, Chief Medical Officer and Director
2011-04-20 Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011.
2012-04-11 Patrick J. Scannon, M.D. Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. ... Dr. Scannon (Executive Vice President and Chief Scientific Officer) is not listed in the director compensation table because he received no additional compensation for services as a member of the Board or its committees. ... Summary Compensation Table shows total compensation of $919,738 for 2011.
2013-04-11 Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011.
2014-04-11 Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011.
2015-04-10 Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011.
2016-04-08 Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011.
2016-09-12 Patrick J. Scannon, M.D., Ph.D. is listed as a director with beneficial ownership in the proxy statement on pages 13-14.

Data sourced from SEC filings. Last updated: 2025-08-30